FEATURED VIDEO: Tardive Dyskinesia Part One
Tardive dyskinesia (TD) is a possible abnormal movements side-effect of antipsychotic medications. TD may cause involuntary movements in the face, extremities and body.
After decades of not being treatable, since 2017, FDA-approved treatment for TD is now available. TD movements differ from other involuntary movements including drug-induced parkinsonism, akathisia and dystonia, and TD movements are treated differently.
CURESZ Foundation Editorial Board:
Editor-In-Chief Bethany Yeiser, BS
Deputy Editor Henry A. Nasrallah, MD
Karen S. Yeiser, RN
David E. Yeiser, M. Div
Robert Cotes, MD
Mary Beth De Bord, JD
Megan Good, MD
Danielle Johnson, MD
Peirce Johnston, MD
Matcheri Keshavan, MD
James A. Hunt, JD
Carol North, MD, MPE
Stephen Rush, MD
Jeffrey Strawn, MD
Rajiv Tandon, MD
Please consider making a donation to the CURESZ Foundation online at CURESZ.org Your contribution will help provide education and referrals to persons with schizophrenia, their families, and those who work with the seriously mentally ill. CURESZ informs the general public to better understand this serious brain disorder, and to provide scientific advances showing that there is hope for recovery, and a return to a fulfilling and normal life. The CURESZ Foundation is a 501(c)(3) nonprofit organization. All contributions are tax deductible.
